FIGURE 5.
During cycle 23 of metronomic temozolomide, magnetic resonance imaging of brain with contrast shows a further decrease in the size of the lesions compared with that see in imaging during cycle 9 (Figure 4).
During cycle 23 of metronomic temozolomide, magnetic resonance imaging of brain with contrast shows a further decrease in the size of the lesions compared with that see in imaging during cycle 9 (Figure 4).